Stay updated on NC410 Plus Pembrolizumab Clinical Trial
Sign up to get notified when there's something new on the NC410 Plus Pembrolizumab Clinical Trial page.
Latest updates to the NC410 Plus Pembrolizumab Clinical Trial page
- Check2 days agoChange DetectedThe website has been updated from version v2.14.1 to v2.14.2.SummaryDifference0.3%
- Check9 days agoNo Change Detected
- Check16 days agoChange DetectedThe website has been updated from version 2.14.0 to 2.14.1.SummaryDifference0.3%
- Check23 days agoChange DetectedThe website has updated the 'type of intervention' feature from version 2.13.3 to 2.14.0, indicating a significant change in this functionality.SummaryDifference1.0%
- Check45 days agoChange DetectedThe study titled 'A Safety, Tolerability and Efficacy Study of NC410 Plus Pembrolizumab in Participants with Advanced Unresectable or Metastatic Solid Tumors' has transitioned from 'Recruiting' to 'Active, not recruiting', with a new date set for 2024-12-16.SummaryDifference2%
- Check52 days agoChange DetectedThe website has been updated from version v2.13.2 to v2.13.3.SummaryDifference0.3%
- Check59 days agoChange DetectedThe website has been updated from version v2.12.2 to v2.13.2, indicating a new release with potential improvements or features.SummaryDifference0.3%
Stay in the know with updates to NC410 Plus Pembrolizumab Clinical Trial
Enter your email address, and we'll notify you when there's something new on the NC410 Plus Pembrolizumab Clinical Trial page.